Today there is no one test for the determination of coronary artery disease at the point-of-care.

HEARTio is a digital diagnostic startup utilizing artificial intelligence in conjunction with the electrocardiogram to help clinicians identify cardiovascular disease more quickly, more accurately, and at a fraction of the cost.

HEARTio is bringing the power of artificial intelligence to the first cardiovascular test in the diagnostic pathway, the electrocardiogram (ECG), to provide exponentially more information than current ECG analysis. HEARTio’s flagship product, ECGio, is an AI platform that brings the power of deep learning to a clinician’s fingertips. ECGio is a stronger diagnostic tool that takes seconds to use, without the need for specialized training or workflow adjustments. ECGio’s diagnostic power rivals that of further downstream testing in validation studies in predicting the presence, and severity of coronary artery disease.